References
- Little JB. Radiation carcinogenesis. Carcinogenesis. 2000;21(3):397–404.
- Hsu WL, Preston DL, Soda M, et al. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001. Radiat Res. 2013;179:361–382.
- Ozasa K, Shimizu Y, Suyama A, et al. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat Res. 2012;177:229–243.
- Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16:582–598.
- Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392–401.
- Xing F, Saidou J, Watabe K. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci (Landmark Ed). 2010;15:166–179.
- Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007;127:526–537.
- Tlsty TD, Coussens LM. Tumor stroma and regulation of cancer development. Annu Rev Pathol. 2006;1:119–150.
- Shimura T, Sasatani M, Kawai H, et al. Radiation-Induced Myofibroblasts Promote Tumor Growth via Mitochondrial ROS-Activated TGFbeta Signaling. Mol Cancer Res. 2018;16:1676–1686.
- Samarakoon R, Overstreet JM, Higgins PJ. TGF-beta signaling in tissue fibrosis: redox controls, target genes and therapeutic opportunities. Cell Signal. 2013;25:264–268.
- Pohlers D, Brenmoehl J, Loffler I, et al. TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta. 2009;1792:746–756.
- Anscher MS. Targeting the TGF-beta1 pathway to prevent normal tissue injury after cancer therapy. Oncologist. 2010;15:350–359.
- Shimura T, Sasatani M, Kamiya K, et al. Mitochondrial reactive oxygen species perturb AKT/cyclin D1 cell cycle signaling via oxidative inactivation of PP2A in lowdose irradiated human fibroblasts. Oncotarget. 2016;7:3559–3570.
- Shimura K, Miyazawa T, Hanaoka T, et al. Fischer-Tropsch synthesis over alumina supported cobalt catalyst: effect of crystal phase and pore structure of alumina support. J Mol Catal A Chem. 2014;394:22–32.
- Shimura T, Sasatani M, Kawai H, et al. ATM-mediated mitochondrial damage response triggered by nuclear DNA damage in normal human lung fibroblasts. Cell Cycle. 2017;16:2345–2354.
- Shimura T, Martin MM, Torres MJ, et al. DNA-PK is involved in repairing a transient surge of DNA breaks induced by deceleration of DNA replication. J Mol Biol. 2007;367:665–680.
- Shimura T, Ochiai Y, Noma N, et al. Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells. Cell Cycle. 2013;12:773–782.
- Shimura T, Toyoshima M, Adiga SK, et al. Suppression of replication fork progression in low-dose-specic p53-dependent S-phase DNA damage checkpoint. Oncogene. 2006;25:5921–5932.
- Shimura T, Koyama M, Aono D, et al. Epicatechin as a promising agent to countermeasure radiation exposure by mitigating mitochondrial damage in human fibroblasts and mouse hematopoietic cells. Faseb J. 2019;33:6867–6876.
- Kutanzi KR, Lumen A, Koturbash I, et al. Pediatric Exposures to Ionizing Radiation: carcinogenic Considerations. Int J Environ Res Public Health. 2016;13:1057
- Shimura T, Kunugita N. Mitochondrial reactive oxygen species-mediated genomic instability in low-dose irradiated human cells through nuclear retention of cyclin D1. Cell Cycle (Georgetown, Tex). 2016;15:1410–1414.
- Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9:283–289.
- Shimura T, Kobayashi J, Komatsu K, et al. Severe mitochondrial damage associated with low-dose radiation sensitivity in ATM- and NBS1-deficient cells. Cell Cycle (Georgetown, Tex). 2016;15:1099–1107.
- Shimura T, Kakuda S, Ochiai Y, et al. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3 beta-mediated cyclin D1 overexpression. Oncogene. 2010;29:4826–4837.